Achieving an itch-free state with upadacitinib: A post-hoc analysis of data from the phase 2b randomized, double-blind, placebo-controlled trial in moderate-to-severe atopic dermatitis

Category Primary study
JournalJournal of the Dermatology Nurses' Association
Year 2020
This article has no abstract
Epistemonikos ID: 7094a51a1d04737977326990358d4b811179f941
First added on: Feb 12, 2025